Table 4.
Study, country | Study design | Exposures | Race | Parity | Definition of exposure | No with pre-eclampsia/No of women | Mean follow-up (years) | No of VTE cases | Relative risk (95% CI) | Degree of adjustment* | |
---|---|---|---|---|---|---|---|---|---|---|---|
Minimum SBP, minimum DBP (mm Hg) | Minimum proteinuria g/24 h | ||||||||||
Hannaford 1997,w8 UK | PC | Pre-eclampsia | 3 | Any | 140, 90 | 0.3 | 2371/17 202 | 12.5† | 150‡ | 1.62 (1.09 to 2.41) | Smoking, socioeconomic status |
Kestenbaum 2003,w14 USA | RC | Mild pre-eclampsia; severe pre-eclampsia and eclampsia | 3; 3 | P, P | 140, 90; 160, 110 | 0.3 | 15 508; 5044/113 454 | 7.8 | 141§; 126§ | 1.4 (0.9 to 2.2); 2.3 (1.3 to 4.2) | |
Van Walraven 2003,w20 Canada | PC | Pre-eclampsia | 1 | Any | 140, 90 | 0.3 | 12 849/297 037 | 3 | 164§ | 2.2 (1.3 to 3.7) | |
Total | : | 35 772/427 693 | 4.7 | 470 |
SBP=systolic blood pressure; DBP=diastolic blood pressure; PC=prospective cohort; RC=retrospective cohort; P=primiparous. All papers adjusted for maternal age, year of birth, and hospital of delivery.
*List of variables used in individual studies to adjust for effect of pre-eclampsia on later risk of chronic disease.
†Calculated from total number of woman years.
‡Codes 450 and 453 from international classification of diseases, ninth revision.
§Codes 415.1 and 451.1 from international classification of diseases, ninth revision.